四磨汤口服液联合西酞普兰治疗伴有焦虑抑郁情绪腹泻型IBS患者的疗效及对5-HT、NE、MPO 影响分析

Effect of Simotang oral liquid combined with citalopram on IBS patients with anxiety, depression and diarrhea and its effect on 5-HT, NE and MPO

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2021, 48(1)
作者
作者单位

安阳市中医院 ;

摘要
【摘要】目的:探讨四磨汤口服液联合西酞普兰治疗伴有焦虑抑郁情绪腹泻型肠易激综合征(IBS)患者的效果及对血清5-羟色胺(5-HT)、去甲肾上腺素(NE)、碎过氧化物酶(MPO)的影响。方法:选取我院2017年1月至2019年6月期间收治的118例伴有焦虑抑郁情绪腹泻型IBS患者作为研究对象,采用随机数字表分为对照组和观察组各59例,两组均给予布拉酵母菌进行治疗,对照组给予西酞普兰治疗,观察组在对照组基础上增加四磨汤口服液进行治疗,疗程1个月,对比两组治疗前后的汉密尔顿抑郁量表(HAMD)评分、汉密尔顿焦虑量表(HAMA)评分、胃肠道临床症状评分、血清5-HT、NE、MPO水平变化及临床疗效。结果:两组患者治疗前HAMD、HAMA评分差异无统计学意义(P>0.05);观察组治疗后HAMD、HAMA评分显著低于对照组(P<0.05);两组患者治疗前血清5-HT、NE、MPO水平差异无统计学意义(P>0.05);观察组治疗后血清MPO水平低于对照组(P<0.05),5-HT、NE水平高于对照组(P<0.05);两组患者治疗前腹泻、腹痛、便急、腹胀评分差异无统计学意义(P>0.05);观察组治疗后腹泻、腹痛、便急、腹胀评分低于对照组(P<0.05);观察组治疗后临床疗效显著优于对照组(P<0.05)。结论:四磨汤口服液联合西酞普兰治疗伴有焦虑抑郁情绪腹泻型IBS患者想确切,可有效调节血清5-HT、NE、MPO水平,改善患者的抑郁焦虑症状,从而进一步改善患者的腹泻IBS临床症状,提高临床疗效。
Abstract
【Abstract】Objective: To explore the effect of Simotang oral liquid combined with citalopram in the treatment of patients with irritable bowel syndrome (IBS) accompanied by anxiety, depression and mood and its effect on serum serotonin (5-HT) and norepinephrine (NE), the impact of broken peroxidase (MPO). Methods: A total of 118 patients with IBS with anxiety, depression, and diarrhea who were admitted to our hospital from January 2017 to June 2019 were selected as the research subjects. They were divided into a random number table into a control group and an observation group, 59 cases, both groups. Saccharomyces boulardii was treated, and the control group was given citalopram. The observation group was treated with Simotang oral liquid on the basis of the control group for 1 month. The Hamilton Depression Scale (HAMD) was compared between the two groups before and after treatment Score, Hamilton Anxiety Scale (HAMA) score, gastrointestinal clinical symptoms score, serum 5-HT, NE, MPO level changes and clinical efficacy. Results: There was no significant difference in HAMD and HAMA scores between the two groups of patients before treatment (P>0.05); the HAMD and HAMA scores of the observation group after treatment were significantly lower than those of the control group (P<0.05); serum 5-HT of the two groups of patients before treatment , NE and MPO levels were not statistically significant (P>0.05); serum MPO levels in the observation group after treatment were lower than the control group (P<0.05), 5-HT and NE levels were higher than the control group (P<0.05); two Before treatment, the scores of diarrhea, abdominal pain, urgency, and bloating were not statistically significant (P>0.05); the scores of diarrhea, abdominal pain, urgency, and bloating in the observation group were lower than those in the control group (P<0.05); The post-clinical efficacy was significantly better than the control group (P<0.05). Conclusion: Simotang oral liquid combined with citalopram is effective in treating IBS patients with anxiety and depression and diarrhea. It can effectively adjust serum 5-HT, NE, MPO levels, improve patients depression and anxiety symptoms, and further improve patients diarrhea IBS clinical symptoms, improve clinical efficacy.
关键词
【关键词】西酞普兰;焦虑;抑郁;腹泻型;肠易激综合征
KeyWord
[Keywords] citalopram; anxiety; depression; diarrhea type; irritable bowel syndrome
基金项目
页码 162-165
  • 参考文献
  • 相关文献
  • 引用本文

李红波*. 四磨汤口服液联合西酞普兰治疗伴有焦虑抑郁情绪腹泻型IBS患者的疗效及对5-HT、NE、MPO 影响分析 [J]. 国际精神病学杂志. 2021; 48; (1). 162 - 165.

  • 文献评论

相关学者

相关机构